Stay updated on BI 425809 Cognitive & Function Clinical Trial
Sign up to get notified when there's something new on the BI 425809 Cognitive & Function Clinical Trial page.

Latest updates to the BI 425809 Cognitive & Function Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on schizophrenia, while retaining the drug name BI 425809 and its dosage information.SummaryDifference24%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check100 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to BI 425809 Cognitive & Function Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 425809 Cognitive & Function Clinical Trial page.